A Randomized, Open Label, Multi-center Trial of 24-week intervention with Designated Treatment Application for Essential Hypertension as compared with standard life-style modification therapy

A Randomized, Open Label, Multi-center Trial of 24-week intervention with Designated Treatment Application for Essential Hypertension as compared with standard life-style modification therapy - A Randomized, Open Label, Multi-center Trial of 24-week intervention with Designated Treatment Application for Essential Hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033311

Enrollment

140

Registered

2018-07-06

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Interventions

Intervention group: Use the application in addition to standard therapy of hypertension with life-style modification Control group: standard therapy of hypertension with life-style modification

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with mild to moderate essential hypertension using smartphones who are or are not under treatment of hypertension(drugs, etc.)

Exclusion criteria

Exclusion criteria: Patients with severe hypertension, a history of secondary hypertension, cardiovascular / cerebrovascular events, etc.

Design outcomes

Primary

Measure	Time frame
Change in mean 24-hour blood pressure from baseline at Week 24	—

Countries

Japan

Contacts

Public ContactTaeko Kikuchi

CureApp, Inc. Regulatory and Clinical Affairs

t-kikuchi@cureapp.jp03-6231-0183

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026